Left Ventricular Hypertrophy: Evaluation With Cardiac MRI
Karen G Grajewski1, Jadranka Stojanovska1, El-Sayed H Ibrahim2
1University of Michigan Hospital and Health Systems, Department of Radiology, Division of Cardiothoracic Imaging, Ann Arbor, MI.
Insights
Cardiac MRI (CMR) aids in diagnosing the causes of left ventricular hypertrophy (LVH). CMR provides detailed analysis of hypertrophy, function, and tissue characteristics to guide prognosis and treatment.
Area of Science:
- Cardiology
- Radiology
- Medical Imaging
Background:
- Left ventricular hypertrophy (LVH) presents diverse etiologies, often challenging clinical diagnosis.
- Cardiac Magnetic Resonance (CMR) is increasingly utilized for evaluating LVH.
- Accurate etiological diagnosis is crucial for effective patient management.
Purpose of the Study:
- To review CMR findings across various causes of LVH.
- To emphasize CMR's role in etiological determination.
- To highlight CMR's emerging utility in risk stratification for LVH patients.
Main Methods:
- Review of CMR imaging findings in different LVH etiologies.
- Emphasis on diagnostic patterns and tissue characterization techniques.
- Discussion of CMR's contribution to risk assessment.
Main Results:
- CMR precisely quantifies hypertrophy severity and distribution.
- CMR effectively evaluates ventricular function and provides tissue characterization.
- CMR findings aid in differentiating various causes of LVH.
Conclusions:
- CMR is invaluable for assessing LVH, determining its cause, and guiding therapy.
- CMR enhances understanding of LVH pathophysiology and prognosis.
- Advanced CMR techniques improve diagnostic accuracy and risk stratification.
Objective:
Left ventricular hypertrophy (LVH) is a frequent problem in clinical practice and can be caused by diverse conditions including hypertension, aortic stenosis, hypertrophic cardiomyopathy, athletic training, infiltrative heart muscle disease, storage and metabolic disorders. Identification of the precise etiology can be challenging and is a common cause of referral for cardiac MRI (CMR). In this article, CMR findings in various causes of LVH will be reviewed with an emphasis on determination of etiology and emerging role of CMR in risk stratification.
Conclusions:
In patients with LVH, CMR allows precise determination of the severity and distribution of hypertrophy, evaluation of ventricular function, and tissue characterization. The information obtained from CMR enables identification of the etiology of LVH and may aid in determining prognosis and therapy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Imaging Studies for Cardiovascular System IV: CMRI
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation I: Introduction


